Literature DB >> 26351889

Robotic-Assisted Surgery in the Head and Neck.

Jon Burton1, Robert Wong, Tapan Padhya.   

Abstract

BACKGROUND: Robotic surgery was first used in medicine in the 1980s for laparoscopic surgery. Since then, several developments have been made in the use of robotic surgery for patients with head and neck cancer.
METHODS: A review was performed of the literature on robotic surgery in patients with head and neck cancer. The various sites of application are discussed in depth as well as the functional and oncological outcomes associated with the most common application of transoral robotic surgery (TORS).
RESULTS: Robotic surgery has been used in all aspects of head and neck surgery. The results from early studies of TORS have shown at least equivalent functional and oncological outcomes.
CONCLUSIONS: Robotic surgery has feasible utility in patients with head and neck cancer; moreover, in several circumstances it may provide superior cosmetic, functional, and oncological outcomes than conventional methods.

Entities:  

Mesh:

Year:  2015        PMID: 26351889     DOI: 10.1177/107327481502200311

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  4 in total

Review 1.  Robotic retroauricular thyroidectomy: initial experience from India.

Authors:  Krishnakumar Thankappan; Surender Dabas; Mandar Deshpande
Journal:  Gland Surg       Date:  2017-06

2.  Initiating a Robotic Thyroidectomy Program in India.

Authors:  Krishnakumar Thankappan; Subramania Iyer
Journal:  Indian J Surg Oncol       Date:  2018-04-05

Review 3.  Robotic Surgery: A Narrative Review.

Authors:  Sakshi Bramhe; Swanand S Pathak
Journal:  Cureus       Date:  2022-09-15

4.  New method of sentinel lymph node biopsy in transoral robotic surgery for oropharyngeal squamous cell carcinoma.

Authors:  Marco Aurélio V Kulcsar; Natasha Sobreira Canovas; Vergilius Jose Furtado de Araujo-Neto; Jorge Du Ub Kim; Claudio Roberto Cernea
Journal:  Clinics (Sao Paulo)       Date:  2018-12-10       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.